Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adipose microenvironment promotes hypersialylation of ovarian cancer cells.
Fox A, Leonard GD, Adzibolosu N, Wong T, Tedja R, Sharma S, Gogoi R, Morris R, Mor G, Fehl C, Alvero AB. Fox A, et al. Among authors: tedja r. Front Oncol. 2024 Jul 22;14:1432333. doi: 10.3389/fonc.2024.1432333. eCollection 2024. Front Oncol. 2024. PMID: 39104719 Free PMC article.
Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells.
Zhang Y, Tedja R, Millman M, Wong T, Fox A, Chehade H, Gershater M, Adzibolosu N, Gogoi R, Anderson M, Rutherford T, Zhang Z, Chopp M, Mor G, Alvero AB. Zhang Y, et al. Among authors: tedja r. bioRxiv [Preprint]. 2023 Nov 10:2023.11.07.566022. doi: 10.1101/2023.11.07.566022. bioRxiv. 2023. Update in: J Ovarian Res. 2023 Nov 30;16(1):233. doi: 10.1186/s13048-023-01312-0 PMID: 37986971 Free PMC article. Updated. Preprint.
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer.
Adzibolosu N, Alvero AB, Ali-Fehmi R, Gogoi R, Corey L, Tedja R, Chehade H, Gogoi V, Morris R, Anderson M, Vitko J, Lam C, Craig DB, Draghici S, Rutherford T, Mor G. Adzibolosu N, et al. Among authors: tedja r. Front Immunol. 2023 Jun 26;14:1204148. doi: 10.3389/fimmu.2023.1204148. eCollection 2023. Front Immunol. 2023. PMID: 37435088 Free PMC article.
MNRR1 is a driver of ovarian cancer progression.
Chehade H, Purandare N, Fox A, Adzibolosu N, Jayee S, Singh A, Tedja R, Gogoi R, Aras S, Grossman LI, Mor G, Alvero AB. Chehade H, et al. Among authors: tedja r. Transl Oncol. 2023 Mar;29:101623. doi: 10.1016/j.tranon.2023.101623. Epub 2023 Jan 13. Transl Oncol. 2023. PMID: 36641875 Free PMC article.
27 results